The global market for Rare Disease CRO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Rare disease CRO (Contract Research Organization) service refers to the specialized research and clinical trial services tailored to address the unique needs of drug development for rare diseases. These services may include clinical trial design, patient recruitment, regulatory support, and data analysis specifically focused on rare disease therapeutics.

North American market for Rare Disease CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Rare Disease CRO Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Rare Disease CRO Service in Cardiovascular is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Rare Disease CRO Service include Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp, Novotech, Syneos Health, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Rare Disease CRO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Disease CRO Service.

The Rare Disease CRO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rare Disease CRO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rare Disease CRO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Rare Disease CRO Service Market Report

Report Metric	Details
Report Name	Rare Disease CRO Service Market
Segment by Type	Drug Development Strategy Clinical Trial Management
Segment by Application	Cardiovascular Neuroscience Ophthalmology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp, Novotech, Syneos Health, Vial, Machaon Diagnostics, Caidya, Simbec Orion, Linical, MMS, Veristat, Celero, Rho, PROMETRIKA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rare Disease CRO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rare Disease CRO Service Market report?

Ans: The main players in the Rare Disease CRO Service Market are Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp, Novotech, Syneos Health, Vial, Machaon Diagnostics, Caidya, Simbec Orion, Linical, MMS, Veristat, Celero, Rho, PROMETRIKA

What are the Application segmentation covered in the Rare Disease CRO Service Market report?

Ans: The Applications covered in the Rare Disease CRO Service Market report are Cardiovascular, Neuroscience, Ophthalmology, Others

What are the Type segmentation covered in the Rare Disease CRO Service Market report?

Ans: The Types covered in the Rare Disease CRO Service Market report are Drug Development Strategy, Clinical Trial Management

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rare Disease CRO Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drug Development Strategy

1.2.3 Clinical Trial Management

1.3 Market by Application

1.3.1 Global Rare Disease CRO Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cardiovascular

1.3.3 Neuroscience

1.3.4 Ophthalmology

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Rare Disease CRO Service Market Perspective (2020-2031)

2.2 Global Rare Disease CRO Service Growth Trends by Region

2.2.1 Global Rare Disease CRO Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Rare Disease CRO Service Historic Market Size by Region (2020-2025)

2.2.3 Rare Disease CRO Service Forecasted Market Size by Region (2026-2031)

2.3 Rare Disease CRO Service Market Dynamics

2.3.1 Rare Disease CRO Service Industry Trends

2.3.2 Rare Disease CRO Service Market Drivers

2.3.3 Rare Disease CRO Service Market Challenges

2.3.4 Rare Disease CRO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Rare Disease CRO Service Players by Revenue

3.1.1 Global Top Rare Disease CRO Service Players by Revenue (2020-2025)

3.1.2 Global Rare Disease CRO Service Revenue Market Share by Players (2020-2025)

3.2 Global Rare Disease CRO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Rare Disease CRO Service Revenue

3.4 Global Rare Disease CRO Service Market Concentration Ratio

3.4.1 Global Rare Disease CRO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rare Disease CRO Service Revenue in 2024

3.5 Global Key Players of Rare Disease CRO Service Head office and Area Served

3.6 Global Key Players of Rare Disease CRO Service, Product and Application

3.7 Global Key Players of Rare Disease CRO Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease CRO Service Breakdown Data by Type

4.1 Global Rare Disease CRO Service Historic Market Size by Type (2020-2025)

4.2 Global Rare Disease CRO Service Forecasted Market Size by Type (2026-2031)

5 Rare Disease CRO Service Breakdown Data by Application

5.1 Global Rare Disease CRO Service Historic Market Size by Application (2020-2025)

5.2 Global Rare Disease CRO Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Rare Disease CRO Service Market Size (2020-2031)

6.2 North America Rare Disease CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Rare Disease CRO Service Market Size by Country (2020-2025)

6.4 North America Rare Disease CRO Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Rare Disease CRO Service Market Size (2020-2031)

7.2 Europe Rare Disease CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Rare Disease CRO Service Market Size by Country (2020-2025)

7.4 Europe Rare Disease CRO Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Rare Disease CRO Service Market Size (2020-2031)

8.2 Asia-Pacific Rare Disease CRO Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Rare Disease CRO Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Rare Disease CRO Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Rare Disease CRO Service Market Size (2020-2031)

9.2 Latin America Rare Disease CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Rare Disease CRO Service Market Size by Country (2020-2025)

9.4 Latin America Rare Disease CRO Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Rare Disease CRO Service Market Size (2020-2031)

10.2 Middle East & Africa Rare Disease CRO Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Rare Disease CRO Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Rare Disease CRO Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Precision for Medicine

11.1.1 Precision for Medicine Company Details

11.1.2 Precision for Medicine Business Overview

11.1.3 Precision for Medicine Rare Disease CRO Service Introduction

11.1.4 Precision for Medicine Revenue in Rare Disease CRO Service Business (2020-2025)

11.1.5 Precision for Medicine Recent Development

11.2 Orphan-Reach

11.2.1 Orphan-Reach Company Details

11.2.2 Orphan-Reach Business Overview

11.2.3 Orphan-Reach Rare Disease CRO Service Introduction

11.2.4 Orphan-Reach Revenue in Rare Disease CRO Service Business (2020-2025)

11.2.5 Orphan-Reach Recent Development

11.3 Medpace

11.3.1 Medpace Company Details

11.3.2 Medpace Business Overview

11.3.3 Medpace Rare Disease CRO Service Introduction

11.3.4 Medpace Revenue in Rare Disease CRO Service Business (2020-2025)

11.3.5 Medpace Recent Development

11.4 Parexel

11.4.1 Parexel Company Details

11.4.2 Parexel Business Overview

11.4.3 Parexel Rare Disease CRO Service Introduction

11.4.4 Parexel Revenue in Rare Disease CRO Service Business (2020-2025)

11.4.5 Parexel Recent Development

11.5 PPD

11.5.1 PPD Company Details

11.5.2 PPD Business Overview

11.5.3 PPD Rare Disease CRO Service Introduction

11.5.4 PPD Revenue in Rare Disease CRO Service Business (2020-2025)

11.5.5 PPD Recent Development

11.6 Worldwide Clinical Trials

11.6.1 Worldwide Clinical Trials Company Details

11.6.2 Worldwide Clinical Trials Business Overview

11.6.3 Worldwide Clinical Trials Rare Disease CRO Service Introduction

11.6.4 Worldwide Clinical Trials Revenue in Rare Disease CRO Service Business (2020-2025)

11.6.5 Worldwide Clinical Trials Recent Development

11.7 AllStripes

11.7.1 AllStripes Company Details

11.7.2 AllStripes Business Overview

11.7.3 AllStripes Rare Disease CRO Service Introduction

11.7.4 AllStripes Revenue in Rare Disease CRO Service Business (2020-2025)

11.7.5 AllStripes Recent Development

11.8 LabCorp

11.8.1 LabCorp Company Details

11.8.2 LabCorp Business Overview

11.8.3 LabCorp Rare Disease CRO Service Introduction

11.8.4 LabCorp Revenue in Rare Disease CRO Service Business (2020-2025)

11.8.5 LabCorp Recent Development

11.9 Novotech

11.9.1 Novotech Company Details

11.9.2 Novotech Business Overview

11.9.3 Novotech Rare Disease CRO Service Introduction

11.9.4 Novotech Revenue in Rare Disease CRO Service Business (2020-2025)

11.9.5 Novotech Recent Development

11.10 Syneos Health

11.10.1 Syneos Health Company Details

11.10.2 Syneos Health Business Overview

11.10.3 Syneos Health Rare Disease CRO Service Introduction

11.10.4 Syneos Health Revenue in Rare Disease CRO Service Business (2020-2025)

11.10.5 Syneos Health Recent Development

11.11 Vial

11.11.1 Vial Company Details

11.11.2 Vial Business Overview

11.11.3 Vial Rare Disease CRO Service Introduction

11.11.4 Vial Revenue in Rare Disease CRO Service Business (2020-2025)

11.11.5 Vial Recent Development

11.12 Machaon Diagnostics

11.12.1 Machaon Diagnostics Company Details

11.12.2 Machaon Diagnostics Business Overview

11.12.3 Machaon Diagnostics Rare Disease CRO Service Introduction

11.12.4 Machaon Diagnostics Revenue in Rare Disease CRO Service Business (2020-2025)

11.12.5 Machaon Diagnostics Recent Development

11.13 Caidya

11.13.1 Caidya Company Details

11.13.2 Caidya Business Overview

11.13.3 Caidya Rare Disease CRO Service Introduction

11.13.4 Caidya Revenue in Rare Disease CRO Service Business (2020-2025)

11.13.5 Caidya Recent Development

11.14 Simbec Orion

11.14.1 Simbec Orion Company Details

11.14.2 Simbec Orion Business Overview

11.14.3 Simbec Orion Rare Disease CRO Service Introduction

11.14.4 Simbec Orion Revenue in Rare Disease CRO Service Business (2020-2025)

11.14.5 Simbec Orion Recent Development

11.15 Linical

11.15.1 Linical Company Details

11.15.2 Linical Business Overview

11.15.3 Linical Rare Disease CRO Service Introduction

11.15.4 Linical Revenue in Rare Disease CRO Service Business (2020-2025)

11.15.5 Linical Recent Development

11.16 MMS

11.16.1 MMS Company Details

11.16.2 MMS Business Overview

11.16.3 MMS Rare Disease CRO Service Introduction

11.16.4 MMS Revenue in Rare Disease CRO Service Business (2020-2025)

11.16.5 MMS Recent Development

11.17 Veristat

11.17.1 Veristat Company Details

11.17.2 Veristat Business Overview

11.17.3 Veristat Rare Disease CRO Service Introduction

11.17.4 Veristat Revenue in Rare Disease CRO Service Business (2020-2025)

11.17.5 Veristat Recent Development

11.18 Celero

11.18.1 Celero Company Details

11.18.2 Celero Business Overview

11.18.3 Celero Rare Disease CRO Service Introduction

11.18.4 Celero Revenue in Rare Disease CRO Service Business (2020-2025)

11.18.5 Celero Recent Development

11.19 Rho

11.19.1 Rho Company Details

11.19.2 Rho Business Overview

11.19.3 Rho Rare Disease CRO Service Introduction

11.19.4 Rho Revenue in Rare Disease CRO Service Business (2020-2025)

11.19.5 Rho Recent Development

11.20 PROMETRIKA

11.20.1 PROMETRIKA Company Details

11.20.2 PROMETRIKA Business Overview

11.20.3 PROMETRIKA Rare Disease CRO Service Introduction

11.20.4 PROMETRIKA Revenue in Rare Disease CRO Service Business (2020-2025)

11.20.5 PROMETRIKA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Precision for Medicine

Medpace

PPD

Worldwide Clinical Trials

List of Tables

Table 1. Global Rare Disease CRO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drug Development Strategy

Table 3. Key Players of Clinical Trial Management

Table 4. Global Rare Disease CRO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Rare Disease CRO Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Rare Disease CRO Service Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Rare Disease CRO Service Market Share by Region (2020-2025)

Table 8. Global Rare Disease CRO Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Rare Disease CRO Service Market Share by Region (2026-2031)

Table 10. Rare Disease CRO Service Market Trends

Table 11. Rare Disease CRO Service Market Drivers

Table 12. Rare Disease CRO Service Market Challenges

Table 13. Rare Disease CRO Service Market Restraints

Table 14. Global Rare Disease CRO Service Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Rare Disease CRO Service Market Share by Players (2020-2025)

Table 16. Global Top Rare Disease CRO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease CRO Service as of 2024)

Table 17. Ranking of Global Top Rare Disease CRO Service Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Rare Disease CRO Service Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Rare Disease CRO Service, Headquarters and Area Served

Table 20. Global Key Players of Rare Disease CRO Service, Product and Application

Table 21. Global Key Players of Rare Disease CRO Service, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Rare Disease CRO Service Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Rare Disease CRO Service Revenue Market Share by Type (2020-2025)

Table 25. Global Rare Disease CRO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Rare Disease CRO Service Revenue Market Share by Type (2026-2031)

Table 27. Global Rare Disease CRO Service Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Rare Disease CRO Service Revenue Market Share by Application (2020-2025)

Table 29. Global Rare Disease CRO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Rare Disease CRO Service Revenue Market Share by Application (2026-2031)

Table 31. North America Rare Disease CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Rare Disease CRO Service Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Rare Disease CRO Service Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Rare Disease CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Rare Disease CRO Service Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Rare Disease CRO Service Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Rare Disease CRO Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Rare Disease CRO Service Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Rare Disease CRO Service Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rare Disease CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Rare Disease CRO Service Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Rare Disease CRO Service Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Rare Disease CRO Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Rare Disease CRO Service Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Rare Disease CRO Service Market Size by Country (2026-2031) & (US$ Million)

Table 46. Precision for Medicine Company Details

Table 47. Precision for Medicine Business Overview

Table 48. Precision for Medicine Rare Disease CRO Service Product

Table 49. Precision for Medicine Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 50. Precision for Medicine Recent Development

Table 51. Orphan-Reach Company Details

Table 52. Orphan-Reach Business Overview

Table 53. Orphan-Reach Rare Disease CRO Service Product

Table 54. Orphan-Reach Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 55. Orphan-Reach Recent Development

Table 56. Medpace Company Details

Table 57. Medpace Business Overview

Table 58. Medpace Rare Disease CRO Service Product

Table 59. Medpace Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 60. Medpace Recent Development

Table 61. Parexel Company Details

Table 62. Parexel Business Overview

Table 63. Parexel Rare Disease CRO Service Product

Table 64. Parexel Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 65. Parexel Recent Development

Table 66. PPD Company Details

Table 67. PPD Business Overview

Table 68. PPD Rare Disease CRO Service Product

Table 69. PPD Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 70. PPD Recent Development

Table 71. Worldwide Clinical Trials Company Details

Table 72. Worldwide Clinical Trials Business Overview

Table 73. Worldwide Clinical Trials Rare Disease CRO Service Product

Table 74. Worldwide Clinical Trials Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 75. Worldwide Clinical Trials Recent Development

Table 76. AllStripes Company Details

Table 77. AllStripes Business Overview

Table 78. AllStripes Rare Disease CRO Service Product

Table 79. AllStripes Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 80. AllStripes Recent Development

Table 81. LabCorp Company Details

Table 82. LabCorp Business Overview

Table 83. LabCorp Rare Disease CRO Service Product

Table 84. LabCorp Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 85. LabCorp Recent Development

Table 86. Novotech Company Details

Table 87. Novotech Business Overview

Table 88. Novotech Rare Disease CRO Service Product

Table 89. Novotech Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 90. Novotech Recent Development

Table 91. Syneos Health Company Details

Table 92. Syneos Health Business Overview

Table 93. Syneos Health Rare Disease CRO Service Product

Table 94. Syneos Health Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 95. Syneos Health Recent Development

Table 96. Vial Company Details

Table 97. Vial Business Overview

Table 98. Vial Rare Disease CRO Service Product

Table 99. Vial Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 100. Vial Recent Development

Table 101. Machaon Diagnostics Company Details

Table 102. Machaon Diagnostics Business Overview

Table 103. Machaon Diagnostics Rare Disease CRO Service Product

Table 104. Machaon Diagnostics Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 105. Machaon Diagnostics Recent Development

Table 106. Caidya Company Details

Table 107. Caidya Business Overview

Table 108. Caidya Rare Disease CRO Service Product

Table 109. Caidya Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 110. Caidya Recent Development

Table 111. Simbec Orion Company Details

Table 112. Simbec Orion Business Overview

Table 113. Simbec Orion Rare Disease CRO Service Product

Table 114. Simbec Orion Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 115. Simbec Orion Recent Development

Table 116. Linical Company Details

Table 117. Linical Business Overview

Table 118. Linical Rare Disease CRO Service Product

Table 119. Linical Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 120. Linical Recent Development

Table 121. MMS Company Details

Table 122. MMS Business Overview

Table 123. MMS Rare Disease CRO Service Product

Table 124. MMS Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 125. MMS Recent Development

Table 126. Veristat Company Details

Table 127. Veristat Business Overview

Table 128. Veristat Rare Disease CRO Service Product

Table 129. Veristat Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 130. Veristat Recent Development

Table 131. Celero Company Details

Table 132. Celero Business Overview

Table 133. Celero Rare Disease CRO Service Product

Table 134. Celero Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 135. Celero Recent Development

Table 136. Rho Company Details

Table 137. Rho Business Overview

Table 138. Rho Rare Disease CRO Service Product

Table 139. Rho Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 140. Rho Recent Development

Table 141. PROMETRIKA Company Details

Table 142. PROMETRIKA Business Overview

Table 143. PROMETRIKA Rare Disease CRO Service Product

Table 144. PROMETRIKA Revenue in Rare Disease CRO Service Business (2020-2025) & (US$ Million)

Table 145. PROMETRIKA Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Rare Disease CRO Service Picture

Figure 2. Global Rare Disease CRO Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rare Disease CRO Service Market Share by Type: 2024 VS 2031

Figure 4. Drug Development Strategy Features

Figure 5. Clinical Trial Management Features

Figure 6. Global Rare Disease CRO Service Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Rare Disease CRO Service Market Share by Application: 2024 VS 2031

Figure 8. Cardiovascular Case Studies

Figure 9. Neuroscience Case Studies

Figure 10. Ophthalmology Case Studies

Figure 11. Others Case Studies

Figure 12. Rare Disease CRO Service Report Years Considered

Figure 13. Global Rare Disease CRO Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Rare Disease CRO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Rare Disease CRO Service Market Share by Region: 2024 VS 2031

Figure 16. Global Rare Disease CRO Service Market Share by Players in 2024

Figure 17. Global Top Rare Disease CRO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease CRO Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Rare Disease CRO Service Revenue in 2024

Figure 19. North America Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Rare Disease CRO Service Market Share by Country (2020-2031)

Figure 21. United States Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Rare Disease CRO Service Market Share by Country (2020-2031)

Figure 25. Germany Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Rare Disease CRO Service Market Share by Region (2020-2031)

Figure 33. China Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Rare Disease CRO Service Market Share by Country (2020-2031)

Figure 41. Mexico Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Rare Disease CRO Service Market Share by Country (2020-2031)

Figure 45. Turkey Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Rare Disease CRO Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Precision for Medicine Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 49. Orphan-Reach Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 50. Medpace Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 51. Parexel Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 52. PPD Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 53. Worldwide Clinical Trials Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 54. AllStripes Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 55. LabCorp Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 56. Novotech Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 57. Syneos Health Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 58. Vial Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 59. Machaon Diagnostics Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 60. Caidya Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 61. Simbec Orion Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 62. Linical Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 63. MMS Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 64. Veristat Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 65. Celero Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 66. Rho Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 67. PROMETRIKA Revenue Growth Rate in Rare Disease CRO Service Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions